FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives

Tečno-čvrsti sistemi kao novi pristup razvoju formulacija i proizvodnji čvrstih farmaceutskih oblika lekova - izazovi i perspektive

Thumbnail
2022
Liquisolid_systems_as_pub_2022.pdf (464.2Kb)
Authors
Aleksić, Ivana
Glišić, Teodora
Parojčić, Jelena
Article (Published version)
Metadata
Show full item record
Abstract
Liquisolid systems are a novel, promising platform for the production of solid dosage forms with a high liquid content, i.e. dispersion of the drug in a suitable, hydrophilic, non-volatile liquid vehicle or liquid drug. This technology requires conventional, but highly porous excipients (carrier and coating material in the appropriate ratio) able to absorb/adsorb liquid medication, resulting in both good flowability and acceptable compression properties. This approach has shown great potential to improve the dissolution rate and bioavailability of poorly soluble drugs, and has been recognized as a good alternative to common, more complex and expensive techniques. A variety of applications of this simple technique have been investigated recently, including the preparation of: modified release tablets, orally disintegrating tablets, solid dosage forms with liquid herbal extracts, etc. This emerging technology has numerous advantages, and the most important are: simplicity, cost...-effectiveness, applicability in large scale production and environmental friendliness. However, it is accompanied by certain challenges as well, such as limited applicability in the case of highly dosed drugs. This article aims to give a comprehensive overview of recent progress regarding the potential applications of this technology, as well as to give an insight into the new liquisolid-based techniques intending to further support its commercial applicability.

Tečno-čvrsti sistemi su nova, obećavajuća platforma za proizvodnju čvrstih farmaceutskih oblika sa visokim sadržajem tečnosti, odnosno disperzije lekovite supstance u pogodnom, hidrofilnom i neisparljivom tečnom vehikulumu ili same lekovite supstance u tečnom agregatnom stanju. Ova tehnologija podrazumeva upotrebu konvencionalnih, ali visoko poroznih ekscipijenasa (nosača i sredstva za oblaganje u odgovarajućem odnosu) koji mogu da absorbuju/adsorbuju tečnost uz zadržavanje dobre protočnosti i prihvatljivih svojstava pri kompresiji. Ovaj pristup je pokazao značajan potencijal da poboljša brzinu rastvaranja i bioraspoloživost slabo rastvorljivih lekovitih supstanci, a prepoznat je kao dobra alternativa uobičajeno primenjivanim, znatno složenijim i skupljim tehnikama. Pored toga, nedavno su istraživane brojne mogućnosti za primenu ove jednostavne tehnike, uključujući izradu: tableta sa modifikovanim oslobađanjem lekovite supstance, oralno disperzibilnih tableta, čvrstih farmaceutskih obl...ika sa tečnim biljnim ekstraktima, itd. Ova nova tehnologija pruža brojne prednosti, među kojima su najvažnije njena jednostavnost, ekonomičnost, primenljivost u industrijskoj proizvodnji i ekološka prihvatljivost. Međutim, prate je i izvesni izazovi, kao što je ograničena primenljivost u slučaju visoko doziranih lekovitih supstanci. Ovaj rad ima za cilj da pruži sveobuhvatan pregled nedavnog napretka u pogledu potencijalne primene ove tehnologije, kao i da pruži uvid u nove tehnike zasnovane na konceptu tečno-čvrstih sistema koje teže da dalje prošire njenu komercijalnu primenu.

Keywords:
porous excipients / tablets / multiparticulate systems / poorly soluble drugs / improved bioavailability / porozni ekscipijensi / tablete / višečestični sistemi / slabo rastvorljive lekovite supstance / poboljšana bioraspoloživost
Source:
Arhiv za farmaciju, 2022, 72, 6, 521-545
Publisher:
  • Pharmaceutical Association of Serbia
Funding / projects:
  • Ministry of Education, Science and Technological Development, Republic of Serbia, Grant no. 200161 (University of Belgrade, Faculty of Pharmacy) (RS-200161)

DOI: 10.5937/arhfarm72-40329

ISSN: 0004-1963

Scopus: 2-s2.0-85148246762
[ Google Scholar ]
URI
https://farfar.pharmacy.bg.ac.rs/handle/123456789/4406
Collections
  • Radovi istraživača / Researchers’ publications
Institution/Community
Pharmacy
TY  - JOUR
AU  - Aleksić, Ivana
AU  - Glišić, Teodora
AU  - Parojčić, Jelena
PY  - 2022
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4406
AB  - Liquisolid systems are a novel, promising platform for the production of solid dosage forms
with a high liquid content, i.e. dispersion of the drug in a suitable, hydrophilic, non-volatile liquid
vehicle or liquid drug. This technology requires conventional, but highly porous excipients
(carrier and coating material in the appropriate ratio) able to absorb/adsorb liquid medication,
resulting in both good flowability and acceptable compression properties. This approach has
shown great potential to improve the dissolution rate and bioavailability of poorly soluble drugs,
and has been recognized as a good alternative to common, more complex and expensive
techniques. A variety of applications of this simple technique have been investigated recently,
including the preparation of: modified release tablets, orally disintegrating tablets, solid dosage
forms with liquid herbal extracts, etc. This emerging technology has numerous advantages, and
the most important are: simplicity, cost-effectiveness, applicability in large scale production and
environmental friendliness. However, it is accompanied by certain challenges as well, such as
limited applicability in the case of highly dosed drugs. This article aims to give a comprehensive
overview of recent progress regarding the potential applications of this technology, as well as to
give an insight into the new liquisolid-based techniques intending to further support its
commercial applicability.
AB  - Tečno-čvrsti sistemi su nova, obećavajuća platforma za proizvodnju čvrstih farmaceutskih oblika sa visokim sadržajem tečnosti, odnosno disperzije lekovite supstance u pogodnom, hidrofilnom i neisparljivom tečnom vehikulumu ili same lekovite supstance u tečnom agregatnom stanju. Ova tehnologija podrazumeva upotrebu konvencionalnih, ali visoko poroznih ekscipijenasa (nosača i sredstva za oblaganje u odgovarajućem odnosu) koji mogu da absorbuju/adsorbuju tečnost uz zadržavanje dobre protočnosti i prihvatljivih svojstava pri kompresiji. Ovaj pristup je pokazao značajan potencijal da poboljša brzinu rastvaranja i bioraspoloživost slabo rastvorljivih lekovitih supstanci, a prepoznat je kao dobra alternativa uobičajeno primenjivanim, znatno složenijim i skupljim tehnikama. Pored toga, nedavno su istraživane brojne mogućnosti za primenu ove jednostavne tehnike, uključujući izradu: tableta sa modifikovanim oslobađanjem lekovite supstance, oralno disperzibilnih tableta, čvrstih farmaceutskih oblika sa tečnim biljnim ekstraktima, itd. Ova nova tehnologija pruža brojne prednosti, među kojima su najvažnije njena jednostavnost, ekonomičnost, primenljivost u industrijskoj proizvodnji i ekološka prihvatljivost. Međutim, prate je i izvesni izazovi, kao što je ograničena primenljivost u slučaju visoko doziranih lekovitih supstanci. Ovaj rad ima za cilj da pruži sveobuhvatan pregled nedavnog napretka u pogledu potencijalne primene ove tehnologije, kao i da pruži uvid u nove tehnike zasnovane na konceptu tečno-čvrstih sistema koje teže da dalje prošire njenu komercijalnu primenu.
PB  - Pharmaceutical Association of Serbia
T2  - Arhiv za farmaciju
T1  - Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives
T1  - Tečno-čvrsti sistemi kao novi pristup razvoju formulacija i proizvodnji čvrstih farmaceutskih oblika lekova - izazovi i perspektive
VL  - 72
IS  - 6
SP  - 521
EP  - 545
DO  - 10.5937/arhfarm72-40329
ER  - 
@article{
author = "Aleksić, Ivana and Glišić, Teodora and Parojčić, Jelena",
year = "2022",
abstract = "Liquisolid systems are a novel, promising platform for the production of solid dosage forms
with a high liquid content, i.e. dispersion of the drug in a suitable, hydrophilic, non-volatile liquid
vehicle or liquid drug. This technology requires conventional, but highly porous excipients
(carrier and coating material in the appropriate ratio) able to absorb/adsorb liquid medication,
resulting in both good flowability and acceptable compression properties. This approach has
shown great potential to improve the dissolution rate and bioavailability of poorly soluble drugs,
and has been recognized as a good alternative to common, more complex and expensive
techniques. A variety of applications of this simple technique have been investigated recently,
including the preparation of: modified release tablets, orally disintegrating tablets, solid dosage
forms with liquid herbal extracts, etc. This emerging technology has numerous advantages, and
the most important are: simplicity, cost-effectiveness, applicability in large scale production and
environmental friendliness. However, it is accompanied by certain challenges as well, such as
limited applicability in the case of highly dosed drugs. This article aims to give a comprehensive
overview of recent progress regarding the potential applications of this technology, as well as to
give an insight into the new liquisolid-based techniques intending to further support its
commercial applicability., Tečno-čvrsti sistemi su nova, obećavajuća platforma za proizvodnju čvrstih farmaceutskih oblika sa visokim sadržajem tečnosti, odnosno disperzije lekovite supstance u pogodnom, hidrofilnom i neisparljivom tečnom vehikulumu ili same lekovite supstance u tečnom agregatnom stanju. Ova tehnologija podrazumeva upotrebu konvencionalnih, ali visoko poroznih ekscipijenasa (nosača i sredstva za oblaganje u odgovarajućem odnosu) koji mogu da absorbuju/adsorbuju tečnost uz zadržavanje dobre protočnosti i prihvatljivih svojstava pri kompresiji. Ovaj pristup je pokazao značajan potencijal da poboljša brzinu rastvaranja i bioraspoloživost slabo rastvorljivih lekovitih supstanci, a prepoznat je kao dobra alternativa uobičajeno primenjivanim, znatno složenijim i skupljim tehnikama. Pored toga, nedavno su istraživane brojne mogućnosti za primenu ove jednostavne tehnike, uključujući izradu: tableta sa modifikovanim oslobađanjem lekovite supstance, oralno disperzibilnih tableta, čvrstih farmaceutskih oblika sa tečnim biljnim ekstraktima, itd. Ova nova tehnologija pruža brojne prednosti, među kojima su najvažnije njena jednostavnost, ekonomičnost, primenljivost u industrijskoj proizvodnji i ekološka prihvatljivost. Međutim, prate je i izvesni izazovi, kao što je ograničena primenljivost u slučaju visoko doziranih lekovitih supstanci. Ovaj rad ima za cilj da pruži sveobuhvatan pregled nedavnog napretka u pogledu potencijalne primene ove tehnologije, kao i da pruži uvid u nove tehnike zasnovane na konceptu tečno-čvrstih sistema koje teže da dalje prošire njenu komercijalnu primenu.",
publisher = "Pharmaceutical Association of Serbia",
journal = "Arhiv za farmaciju",
title = "Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives, Tečno-čvrsti sistemi kao novi pristup razvoju formulacija i proizvodnji čvrstih farmaceutskih oblika lekova - izazovi i perspektive",
volume = "72",
number = "6",
pages = "521-545",
doi = "10.5937/arhfarm72-40329"
}
Aleksić, I., Glišić, T.,& Parojčić, J.. (2022). Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives. in Arhiv za farmaciju
Pharmaceutical Association of Serbia., 72(6), 521-545.
https://doi.org/10.5937/arhfarm72-40329
Aleksić I, Glišić T, Parojčić J. Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives. in Arhiv za farmaciju. 2022;72(6):521-545.
doi:10.5937/arhfarm72-40329 .
Aleksić, Ivana, Glišić, Teodora, Parojčić, Jelena, "Liquisolid systems as a novel approach in formulation and manufacturing of solid dosage forms: Challenges and perspectives" in Arhiv za farmaciju, 72, no. 6 (2022):521-545,
https://doi.org/10.5937/arhfarm72-40329 . .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB